Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
21
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Lesser Brian Andrew | SVP, Commercial Officer | 11 | $0 | $37.5K | 2022-10-14 |
| Melian Agustin | EVP, Research & Development | 4 | $0 | $0 | 2022-10-14 |
| Potts Jeannette | See Remarks | 17 | $0 | $45.7K | 2022-10-14 |
| Lee Frank D. | President and CEO | 14 | $0 | $175.9K | 2022-10-14 |
| Frederick Wayne A.I. | Director | 9 | $0 | $0 | 2022-10-14 |
| Shegog Todd | SVP, Chief Financial Officer | 14 | $0 | $55.6K | 2022-10-14 |
| Shah Rajeev M. | 10% Owner | 10 | $80.00M | $0 | 2022-10-14 |
| MOLINA ARTURO MD | Director | 7 | $0 | $0 | 2022-10-14 |
| Bishop John E | SVP, Chief Technology Officer | 7 | $0 | $0 | 2022-10-14 |
| Fanucci Marsha | Director | 17 | $0 | $0 | 2022-10-14 |
| CLACKSON TIMOTHY P | Director | 15 | $0 | $0 | 2022-10-14 |
| WIGGANS THOMAS G | Director | 9 | $0 | $0 | 2022-10-14 |
| WIRTH PETER | Director | 18 | $0 | $0 | 2022-10-14 |
| Vickers Selwyn M MD | Director | 5 | $0 | $0 | 2022-06-08 |
| Kelly Patrick F. | SVP, Chief Medical Officer | 13 | $0 | $51.3K | 2022-04-13 |
| COOK DAVID N | SVP, Chief Scientific Officer | 7 | $0 | $34.5K | 2022-02-28 |
| Wadlinger Mary E. | See Remarks | 9 | $0 | $45.8K | 2022-02-23 |
| Kolchinsky Peter | Director, 10% Owner | 6 | $80.00M | $0 | 2021-06-17 |
| Paoletti Paolo | Director | 6 | $0 | $0 | 2020-06-23 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | 3 | $20.00M | $0 | 2020-06-23 |
| Hall Steven Edward | Director | 4 | $0 | $0 | 2020-06-23 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Shah Rajeev M. | 10% Owner | D To issuer deriv | 2022-10-14 | 2022-10-14 | 6,750 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | 10% Owner | D To issuer deriv | 2022-10-14 | 2022-10-14 | 17,533 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | 10% Owner | D To issuer deriv | 2022-10-14 | 2022-10-14 | 8,375 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 28,053 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 9,351 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 14,026 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 6,750 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 8,375 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 17,533 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 14,026 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 28,053 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 17,533 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 8,375 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 6,750 | — | $0 | 0 | SEC↗ |
| WIGGANS THOMAS G | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 6,750 | — | $0 | 0 | SEC↗ |
| WIGGANS THOMAS G | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 25,000 | — | $0 | 0 | SEC↗ |
| WIGGANS THOMAS G | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 8,375 | — | $0 | 0 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | D To issuer deriv | 2022-10-14 | 2022-10-14 | 11,689 | — | $0 | 0 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | D To issuer deriv | 2022-10-14 | 2022-10-14 | 153,528 | — | $0 | 0 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | D To issuer deriv | 2022-10-14 | 2022-10-14 | 116,890 | — | $0 | 0 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | D To issuer deriv | 2022-10-14 | 2022-10-14 | 70,134 | — | $0 | 0 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | D To issuer deriv | 2022-10-14 | 2022-10-14 | 50,250 | — | $0 | 0 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | D To issuer deriv | 2022-10-14 | 2022-10-14 | 50,000 | — | $0 | 0 | SEC↗ |
| Bishop John E | SVP, Chief Technology Office | D To issuer deriv | 2022-10-14 | 2022-10-14 | 38,930 | — | $0 | 0 | SEC↗ |
| Bishop John E | SVP, Chief Technology Office | D To issuer deriv | 2022-10-14 | 2022-10-14 | 67,000 | — | $0 | 0 | SEC↗ |
| Melian Agustin | EVP, Research & Development | D To issuer deriv | 2022-10-14 | 2022-10-14 | 118,000 | — | $0 | 0 | SEC↗ |
| MOLINA ARTURO MD | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 16,750 | — | $0 | 0 | SEC↗ |
| MOLINA ARTURO MD | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 6,750 | — | $0 | 0 | SEC↗ |
| Lee Frank D. | President and CEO | D To issuer deriv | 2022-10-14 | 2022-10-14 | 182,500 | — | $0 | 0 | SEC↗ |
| Lee Frank D. | President and CEO | D To issuer deriv | 2022-10-14 | 2022-10-14 | 678,357 | — | $0 | 0 | SEC↗ |
| Lee Frank D. | President and CEO | D To issuer deriv | 2022-10-14 | 2022-10-14 | 70,134 | — | $0 | 0 | SEC↗ |
| Lee Frank D. | President and CEO | D To issuer deriv | 2022-10-14 | 2022-10-14 | 748,100 | — | $0 | 0 | SEC↗ |
| Lee Frank D. | President and CEO | D To issuer deriv | 2022-10-14 | 2022-10-14 | 71,770 | — | $0 | 0 | SEC↗ |
| Lee Frank D. | President and CEO | D To issuer deriv | 2022-10-14 | 2022-10-14 | 175,875 | — | $0 | 0 | SEC↗ |
| Frederick Wayne A.I. | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 25,000 | — | $0 | 0 | SEC↗ |
| Frederick Wayne A.I. | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 6,750 | — | $0 | 0 | SEC↗ |
| Frederick Wayne A.I. | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 8,375 | — | $0 | 0 | SEC↗ |
| Fanucci Marsha | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 14,026 | — | $0 | 0 | SEC↗ |
| Fanucci Marsha | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 28,053 | — | $0 | 0 | SEC↗ |
| Fanucci Marsha | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 17,533 | — | $0 | 0 | SEC↗ |
| Fanucci Marsha | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 8,375 | — | $0 | 0 | SEC↗ |
| Fanucci Marsha | Director | D To issuer deriv | 2022-10-14 | 2022-10-14 | 6,750 | — | $0 | 0 | SEC↗ |
| Potts Jeannette | See Remarks | D To issuer deriv | 2022-10-14 | 2022-10-14 | 37,500 | — | $0 | 0 | SEC↗ |
| Potts Jeannette | See Remarks | D To issuer deriv | 2022-10-14 | 2022-10-14 | 111,746 | — | $0 | 0 | SEC↗ |
| Potts Jeannette | See Remarks | D To issuer deriv | 2022-10-14 | 2022-10-14 | 11,689 | — | $0 | 0 | SEC↗ |
| Potts Jeannette | See Remarks | D To issuer deriv | 2022-10-14 | 2022-10-14 | 105,201 | — | $0 | 0 | SEC↗ |
| Potts Jeannette | See Remarks | D To issuer deriv | 2022-10-14 | 2022-10-14 | 72,004 | — | $0 | 0 | SEC↗ |
| Potts Jeannette | See Remarks | D To issuer deriv | 2022-10-14 | 2022-10-14 | 43,550 | — | $0 | 0 | SEC↗ |
| Lesser Brian Andrew | SVP, Commercial Officer | D To issuer deriv | 2022-10-14 | 2022-10-14 | 17,533 | — | $0 | 0 | SEC↗ |
| Lesser Brian Andrew | SVP, Commercial Officer | D To issuer deriv | 2022-10-14 | 2022-10-14 | 46,756 | — | $0 | 0 | SEC↗ |
| Lesser Brian Andrew | SVP, Commercial Officer | D To issuer deriv | 2022-10-14 | 2022-10-14 | 46,756 | — | $0 | 0 | SEC↗ |
| Lesser Brian Andrew | SVP, Commercial Officer | D To issuer deriv | 2022-10-14 | 2022-10-14 | 32,987 | — | $0 | 0 | SEC↗ |
| Lesser Brian Andrew | SVP, Commercial Officer | D To issuer deriv | 2022-10-14 | 2022-10-14 | 36,850 | — | $0 | 0 | SEC↗ |
| Lesser Brian Andrew | SVP, Commercial Officer | D To issuer deriv | 2022-10-14 | 2022-10-14 | 37,500 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | 10% Owner | U Tender | 2022-10-14 | 2022-10-14 | 1,511,425 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | 10% Owner | U Tender | 2022-10-14 | 2022-10-14 | 7,250 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | 10% Owner | U Tender | 2022-10-14 | 2022-10-14 | 7,500,226 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | Director | U Tender | 2022-10-14 | 2022-10-14 | 7,250 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | Director | U Tender | 2022-10-14 | 2022-10-14 | 23,590 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | U Tender | 2022-10-14 | 2022-10-14 | 127,665 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | U Tender | 2022-10-14 | 2022-10-14 | 7,250 | — | $0 | 0 | SEC↗ |
| WIGGANS THOMAS G | Director | U Tender | 2022-10-14 | 2022-10-14 | 7,250 | — | $0 | 0 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | U Tender | 2022-10-14 | 2022-10-14 | 56,143 | — | $0 | 0 | SEC↗ |
| Bishop John E | SVP, Chief Technology Office | U Tender | 2022-10-14 | 2022-10-14 | 47,950 | — | $0 | 0 | SEC↗ |
| Melian Agustin | EVP, Research & Development | U Tender | 2022-10-14 | 2022-10-14 | 79,000 | — | $0 | 0 | SEC↗ |
| MOLINA ARTURO MD | Director | U Tender | 2022-10-14 | 2022-10-14 | 10,000 | — | $0 | 0 | SEC↗ |
| Lee Frank D. | President and CEO | U Tender | 2022-10-14 | 2022-10-14 | 201,436 | — | $0 | 0 | SEC↗ |
| Frederick Wayne A.I. | Director | U Tender | 2022-10-14 | 2022-10-14 | 7,250 | — | $0 | 0 | SEC↗ |
| Fanucci Marsha | Director | U Tender | 2022-10-14 | 2022-10-14 | 7,250 | — | $0 | 0 | SEC↗ |
| Fanucci Marsha | Director | U Tender | 2022-10-14 | 2022-10-14 | 52,532 | — | $0 | 0 | SEC↗ |
| Potts Jeannette | See Remarks | U Tender | 2022-10-14 | 2022-10-14 | 3,400 | — | $0 | 0 | SEC↗ |
| Potts Jeannette | See Remarks | U Tender | 2022-10-14 | 2022-10-14 | 43,958 | — | $0 | 0 | SEC↗ |
| Lesser Brian Andrew | SVP, Commercial Officer | U Tender | 2022-10-14 | 2022-10-14 | 10,000 | — | $0 | 0 | SEC↗ |
| Lesser Brian Andrew | SVP, Commercial Officer | U Tender | 2022-10-14 | 2022-10-14 | 42,593 | — | $0 | 0 | SEC↗ |
| Melian Agustin | EVP, Research & Development | A Award deriv | 2022-07-11 | 2022-07-12 | 118,000 | — | $0 | 118,000 | SEC↗ |
| Melian Agustin | EVP, Research & Development | A Award | 2022-07-11 | 2022-07-12 | 79,000 | — | $0 | 79,000 | SEC↗ |
| MOLINA ARTURO MD | Director | A Award deriv | 2022-06-08 | 2022-06-09 | 6,750 | — | $0 | 6,750 | SEC↗ |
| Fanucci Marsha | Director | A Award deriv | 2022-06-08 | 2022-06-09 | 6,750 | — | $0 | 6,750 | SEC↗ |
| CLACKSON TIMOTHY P | Director | A Award deriv | 2022-06-08 | 2022-06-09 | 6,750 | — | $0 | 6,750 | SEC↗ |
| WIRTH PETER | Director | A Award deriv | 2022-06-08 | 2022-06-09 | 6,750 | — | $0 | 6,750 | SEC↗ |
| WIGGANS THOMAS G | Director | A Award deriv | 2022-06-08 | 2022-06-09 | 6,750 | — | $0 | 6,750 | SEC↗ |
| Vickers Selwyn M MD | Director | A Award deriv | 2022-06-08 | 2022-06-09 | 6,750 | — | $0 | 6,750 | SEC↗ |
| Frederick Wayne A.I. | Director | A Award deriv | 2022-06-08 | 2022-06-09 | 6,750 | — | $0 | 6,750 | SEC↗ |
| MOLINA ARTURO MD | Director | A Award | 2022-06-08 | 2022-06-09 | 4,500 | — | $0 | 10,000 | SEC↗ |
| Fanucci Marsha | Director | A Award | 2022-06-08 | 2022-06-09 | 4,500 | — | $0 | 59,782 | SEC↗ |
| CLACKSON TIMOTHY P | Director | A Award | 2022-06-08 | 2022-06-09 | 4,500 | — | $0 | 30,840 | SEC↗ |
| WIRTH PETER | Director | A Award | 2022-06-08 | 2022-06-09 | 4,500 | — | $0 | 134,915 | SEC↗ |
| WIGGANS THOMAS G | Director | A Award | 2022-06-08 | 2022-06-09 | 4,500 | — | $0 | 7,250 | SEC↗ |
| Vickers Selwyn M MD | Director | A Award | 2022-06-08 | 2022-06-09 | 4,500 | — | $0 | 7,250 | SEC↗ |
| Frederick Wayne A.I. | Director | A Award | 2022-06-08 | 2022-06-09 | 4,500 | — | $0 | 7,250 | SEC↗ |
| Kelly Patrick F. | SVP, Chief Medical Officer | M Exercise deriv | 2022-04-13 | 2022-04-14 | 15,000 | — | $0 | 55,134 | SEC↗ |
| Kelly Patrick F. | SVP, Chief Medical Officer | M Exercise | 2022-04-08 | 2022-04-14 | 15,000 | $5.05 | $75.8K | 104,884 | SEC↗ |
| Potts Jeannette | See Remarks | A Award deriv | 2022-02-28 | 2022-03-02 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Lesser Brian Andrew | SVP, Commercial | A Award deriv | 2022-02-28 | 2022-03-02 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | A Award deriv | 2022-02-28 | 2022-03-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Kelly Patrick F. | SVP, Chief Medical Officer | A Award deriv | 2022-02-28 | 2022-03-02 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Bishop John E | SVP, Chief Technology Office | A Award deriv | 2022-02-28 | 2022-03-02 | 38,930 | — | $0 | 38,930 | SEC↗ |
| COOK DAVID N | SVP, Chief Scientific Office | A Award deriv | 2022-02-28 | 2022-03-02 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Lee Frank D. | President and CEO | A Award deriv | 2022-02-28 | 2022-03-02 | 182,500 | — | $0 | 182,500 | SEC↗ |
| Potts Jeannette | See Remarks | A Award | 2022-02-28 | 2022-03-02 | 25,000 | — | $0 | 47,358 | SEC↗ |
| Lesser Brian Andrew | SVP, Commercial | A Award | 2022-02-28 | 2022-03-02 | 25,000 | — | $0 | 42,593 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | A Award | 2022-02-28 | 2022-03-02 | 33,330 | — | $0 | 56,143 | SEC↗ |
| Kelly Patrick F. | SVP, Chief Medical Officer | A Award | 2022-02-28 | 2022-03-02 | 25,000 | — | $0 | 89,884 | SEC↗ |
| Bishop John E | SVP, Chief Technology Office | A Award | 2022-02-28 | 2022-03-02 | 25,950 | — | $0 | 47,950 | SEC↗ |
| COOK DAVID N | SVP, Chief Scientific Office | A Award | 2022-02-28 | 2022-03-02 | 25,000 | — | $0 | 41,469 | SEC↗ |
| Lee Frank D. | President and CEO | A Award | 2022-02-28 | 2022-03-02 | 121,667 | — | $0 | 201,436 | SEC↗ |
| Potts Jeannette | See Remarks | S Sale | 2022-02-23 | 2022-02-25 | 4,672 | $9.78 | $45.7K | 22,358 | SEC↗ |
| Wadlinger Mary E. | See Remarks | S Sale | 2022-02-23 | 2022-02-25 | 4,684 | $9.78 | $45.8K | 134,521 | SEC↗ |
| Lesser Brian Andrew | SVP, Commercial | S Sale | 2022-02-23 | 2022-02-25 | 3,837 | $9.78 | $37.5K | 17,593 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | S Sale | 2022-02-23 | 2022-02-25 | 5,687 | $9.78 | $55.6K | 22,813 | SEC↗ |
| Kelly Patrick F. | SVP, Chief Medical Officer | S Sale | 2022-02-23 | 2022-02-25 | 5,245 | $9.78 | $51.3K | 64,884 | SEC↗ |
| Lee Frank D. | President and CEO | S Sale | 2022-02-23 | 2022-02-25 | 17,981 | $9.78 | $175.9K | 79,769 | SEC↗ |
| COOK DAVID N | SVP, Chief Scientific Office | S Sale | 2022-02-23 | 2022-02-25 | 3,531 | $9.78 | $34.5K | 16,469 | SEC↗ |
| MOLINA ARTURO MD | Director | A Award deriv | 2022-01-12 | 2022-01-13 | 16,750 | — | $0 | 16,750 | SEC↗ |
| MOLINA ARTURO MD | Director | A Award | 2022-01-12 | 2022-01-13 | 5,500 | — | $0 | 5,500 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2021-06-17 | 2021-06-21 | 8,375 | — | $0 | 8,375 | SEC↗ |
| WIRTH PETER | Director | A Award deriv | 2021-06-17 | 2021-06-21 | 8,375 | — | $0 | 8,375 | SEC↗ |
| Fanucci Marsha | Director | A Award deriv | 2021-06-17 | 2021-06-21 | 8,375 | — | $0 | 8,375 | SEC↗ |
| CLACKSON TIMOTHY P | Director | A Award deriv | 2021-06-17 | 2021-06-21 | 8,375 | — | $0 | 8,375 | SEC↗ |
| WIGGANS THOMAS G | Director | A Award deriv | 2021-06-17 | 2021-06-21 | 8,375 | — | $0 | 8,375 | SEC↗ |
| Frederick Wayne A.I. | Director | A Award deriv | 2021-06-17 | 2021-06-21 | 8,375 | — | $0 | 8,375 | SEC↗ |
| Vickers Selwyn M MD | Director | A Award deriv | 2021-06-17 | 2021-06-21 | 8,375 | — | $0 | 8,375 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award | 2021-06-17 | 2021-06-21 | 2,750 | — | $0 | 2,750 | SEC↗ |
| WIRTH PETER | Director | A Award | 2021-06-17 | 2021-06-21 | 2,750 | — | $0 | 130,415 | SEC↗ |
| Fanucci Marsha | Director | A Award | 2021-06-17 | 2021-06-21 | 2,750 | — | $0 | 55,282 | SEC↗ |
| CLACKSON TIMOTHY P | Director | A Award | 2021-06-17 | 2021-06-21 | 2,750 | — | $0 | 26,340 | SEC↗ |
| WIGGANS THOMAS G | Director | A Award | 2021-06-17 | 2021-06-21 | 2,750 | — | $0 | 2,750 | SEC↗ |
| Frederick Wayne A.I. | Director | A Award | 2021-06-17 | 2021-06-21 | 2,750 | — | $0 | 2,750 | SEC↗ |
| Vickers Selwyn M MD | Director | A Award | 2021-06-17 | 2021-06-21 | 2,750 | — | $0 | 2,750 | SEC↗ |
| Bishop John E | Chief Technology Officer | A Award deriv | 2021-06-14 | 2021-06-15 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Bishop John E | Chief Technology Officer | A Award | 2021-06-14 | 2021-06-15 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Shah Rajeev M. | 10% Owner | J Other | 2021-04-01 | 2021-04-05 | 542,018 | $28.02 | $15.19M | 7,500,226 | SEC↗ |
| Kelly Patrick F. | Chief Medical Officer | A Award deriv | 2021-02-26 | 2021-03-02 | 50,250 | — | $0 | 50,250 | SEC↗ |
| Lee Frank D. | President and CEO | A Award deriv | 2021-02-26 | 2021-03-02 | 175,875 | — | $0 | 175,875 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | A Award deriv | 2021-02-26 | 2021-03-02 | 50,250 | — | $0 | 0 | SEC↗ |
| COOK DAVID N | SVP, Chief Scientific Office | A Award deriv | 2021-02-26 | 2021-03-02 | 43,550 | — | $0 | 43,550 | SEC↗ |
| Wadlinger Mary E. | See Remarks | A Award deriv | 2021-02-26 | 2021-03-02 | 43,550 | — | $0 | 43,550 | SEC↗ |
| Potts Jeannette | See Remarks | A Award deriv | 2021-02-26 | 2021-03-02 | 43,550 | — | $0 | 43,550 | SEC↗ |
| Kelly Patrick F. | Chief Medical Officer | A Award | 2021-02-26 | 2021-03-02 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Kelly Patrick F. | Chief Medical Officer | A Award | 2021-02-26 | 2021-03-02 | 10,670 | — | $0 | 27,170 | SEC↗ |
| Lee Frank D. | President and CEO | A Award | 2021-02-26 | 2021-03-02 | 57,750 | — | $0 | 57,750 | SEC↗ |
| Lee Frank D. | President and CEO | A Award | 2021-02-26 | 2021-03-02 | 40,000 | — | $0 | 97,750 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | A Award | 2021-02-26 | 2021-03-02 | 12,000 | — | $0 | 28,500 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | A Award | 2021-02-26 | 2021-03-02 | 16,500 | — | $0 | 16,500 | SEC↗ |
| COOK DAVID N | SVP, Chief Scientific Office | A Award | 2021-02-26 | 2021-03-02 | 5,700 | — | $0 | 20,000 | SEC↗ |
| COOK DAVID N | SVP, Chief Scientific Office | A Award | 2021-02-26 | 2021-03-02 | 14,300 | — | $0 | 14,300 | SEC↗ |
| Wadlinger Mary E. | See Remarks | A Award | 2021-02-26 | 2021-03-02 | 14,300 | — | $0 | 129,875 | SEC↗ |
| Wadlinger Mary E. | See Remarks | A Award | 2021-02-26 | 2021-03-02 | 9,330 | — | $0 | 139,205 | SEC↗ |
| Potts Jeannette | See Remarks | A Award | 2021-02-26 | 2021-03-02 | 9,330 | — | $0 | 27,030 | SEC↗ |
| Potts Jeannette | See Remarks | A Award | 2021-02-26 | 2021-03-02 | 14,300 | — | $0 | 17,700 | SEC↗ |
| Potts Jeannette | See Remarks | M Exercise deriv | 2021-01-06 | 2021-01-08 | 3,400 | — | $0 | 111,746 | SEC↗ |
| Vickers Selwyn M MD | Director | A Award deriv | 2021-01-05 | 2021-01-11 | 25,000 | — | $0 | 0 | SEC↗ |
| Potts Jeannette | See Remarks | M Exercise | 2020-12-30 | 2021-01-08 | 3,400 | $5.05 | $17.2K | 3,400 | SEC↗ |
| WIGGANS THOMAS G | Director | A Award deriv | 2020-09-07 | 2020-09-09 | 25,000 | — | $0 | 0 | SEC↗ |
| Frederick Wayne A.I. | Director | A Award deriv | 2020-07-28 | 2020-07-30 | 25,000 | — | $0 | 0 | SEC↗ |
| Hall Steven Edward | Director | C Conversion deriv | 2020-06-23 | 2020-11-25 | 5,833,333 | — | $0 | 0 | SEC↗ |
| Hall Steven Edward | Director | C Conversion deriv | 2020-06-23 | 2020-11-25 | 3,178,630 | — | $0 | 0 | SEC↗ |
| Hall Steven Edward | Director | C Conversion | 2020-06-23 | 2020-11-25 | 2,106,828 | — | $0 | 2,404,069 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | C Conversion deriv | 2020-06-23 | 2020-06-24 | 21,437,376 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | 10% Owner | C Conversion deriv | 2020-06-23 | 2020-06-24 | 21,437,376 | — | $0 | 0 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion deriv | 2020-06-23 | 2020-06-25 | 5,359,344 | — | $0 | 0 | SEC↗ |
| Paoletti Paolo | Director | S Sale | 2020-06-23 | 2020-06-24 | 25,248 | — | $0 | 0 | SEC↗ |
| Paoletti Paolo | Director | S Sale | 2020-06-23 | 2020-06-24 | 9,847 | — | $0 | 0 | SEC↗ |
| Paoletti Paolo | Director | P Buy | 2020-06-23 | 2020-06-24 | 45,553 | — | $0 | 45,553 | SEC↗ |
| Paoletti Paolo | Director | S Sale | 2020-06-23 | 2020-06-24 | 14,026 | — | $0 | 0 | SEC↗ |
| Paoletti Paolo | Director | S Sale | 2020-06-23 | 2020-06-24 | 10,240 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | P Buy | 2020-06-23 | 2020-06-24 | 4,000,000 | $20.00 | $80.00M | 9,011,651 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | C Conversion | 2020-06-23 | 2020-06-24 | 5,011,651 | — | $0 | 5,011,651 | SEC↗ |
| Shah Rajeev M. | 10% Owner | C Conversion | 2020-06-23 | 2020-06-24 | 5,011,651 | — | $0 | 5,011,651 | SEC↗ |
| Shah Rajeev M. | 10% Owner | P Buy | 2020-06-23 | 2020-06-24 | 4,000,000 | $20.00 | $80.00M | 9,011,651 | SEC↗ |
| Wadlinger Mary E. | See Remarks | S Sale | 2020-06-23 | 2020-06-24 | 29,222 | — | $0 | 0 | SEC↗ |
| Wadlinger Mary E. | See Remarks | P Buy | 2020-06-23 | 2020-06-24 | 115,575 | — | $0 | 115,575 | SEC↗ |
| Wadlinger Mary E. | See Remarks | S Sale | 2020-06-23 | 2020-06-24 | 91,876 | — | $0 | 0 | SEC↗ |
| Wadlinger Mary E. | See Remarks | S Sale | 2020-06-23 | 2020-06-24 | 23,354 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | Director | S Sale | 2020-06-23 | 2020-06-24 | 35,067 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | Director | P Buy | 2020-06-23 | 2020-06-24 | 23,590 | — | $0 | 23,590 | SEC↗ |
| Fanucci Marsha | Director | P Buy | 2020-06-23 | 2020-06-24 | 52,532 | — | $0 | 52,532 | SEC↗ |
| Fanucci Marsha | Director | S Sale | 2020-06-23 | 2020-06-24 | 33,781 | — | $0 | 0 | SEC↗ |
| Fanucci Marsha | Director | S Sale | 2020-06-23 | 2020-06-24 | 9,847 | — | $0 | 0 | SEC↗ |
| Fanucci Marsha | Director | S Sale | 2020-06-23 | 2020-06-24 | 10,240 | — | $0 | 0 | SEC↗ |
| Fanucci Marsha | Director | S Sale | 2020-06-23 | 2020-06-24 | 14,026 | — | $0 | 0 | SEC↗ |
| Kelly Patrick F. | Chief Medical Officer | S Sale | 2020-06-23 | 2020-06-24 | 17,533 | — | $0 | 0 | SEC↗ |
| Kelly Patrick F. | Chief Medical Officer | S Sale | 2020-06-23 | 2020-06-24 | 40,911 | — | $0 | 0 | SEC↗ |
| Kelly Patrick F. | Chief Medical Officer | P Buy | 2020-06-23 | 2020-06-24 | 42,959 | — | $0 | 42,959 | SEC↗ |
| Kelly Patrick F. | Chief Medical Officer | S Sale | 2020-06-23 | 2020-06-24 | 5,844 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | S Sale | 2020-06-23 | 2020-06-24 | 9,847 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | S Sale | 2020-06-23 | 2020-06-24 | 25,756 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | S Sale | 2020-06-23 | 2020-06-24 | 10,240 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | S Sale | 2020-06-23 | 2020-06-24 | 18,585 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | P Buy | 2020-06-23 | 2020-06-24 | 63,299 | — | $0 | 127,665 | SEC↗ |
| WIRTH PETER | Director | S Sale | 2020-06-23 | 2020-06-24 | 14,026 | — | $0 | 0 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | P Buy | 2020-06-23 | 2020-06-25 | 1,000,000 | $20.00 | $20.00M | 2,252,913 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion | 2020-06-23 | 2020-06-25 | 1,252,913 | — | $0 | 1,252,913 | SEC↗ |
| Hall Steven Edward | Director | A Award deriv | 2020-06-18 | 2020-06-22 | 17,533 | — | $0 | 0 | SEC↗ |
| Shegog Todd | SVP, Chief Financial Officer | A Award deriv | 2020-06-18 | 2020-06-22 | 70,134 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | Director | A Award deriv | 2020-06-18 | 2020-06-22 | 17,533 | — | $0 | 0 | SEC↗ |
| Kelly Patrick F. | SVP, Chief Medical Officer | A Award deriv | 2020-06-18 | 2020-06-22 | 116,890 | — | $0 | 0 | SEC↗ |
| WIRTH PETER | Director | A Award deriv | 2020-06-18 | 2020-06-22 | 17,533 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2020-06-18 | 2020-06-22 | 17,533 | — | $0 | 0 | SEC↗ |
| Wadlinger Mary E. | See Remarks | A Award deriv | 2020-06-18 | 2020-06-22 | 23,378 | — | $0 | 0 | SEC↗ |
| Paoletti Paolo | Director | A Award deriv | 2020-06-18 | 2020-06-22 | 17,533 | — | $0 | 0 | SEC↗ |
| Fanucci Marsha | Director | A Award deriv | 2020-06-18 | 2020-06-22 | 17,533 | — | $0 | 0 | SEC↗ |
| Lee Frank D. | President and CEO | A Award deriv | 2020-06-18 | 2020-06-22 | 71,770 | — | $0 | 0 | SEC↗ |
| Potts Jeannette | See Remarks | A Award deriv | 2020-06-18 | 2020-06-22 | 72,004 | — | $0 | 0 | SEC↗ |
| COOK DAVID N | SVP, Chief Scientific Office | A Award deriv | 2020-06-18 | 2020-06-22 | 23,378 | — | $0 | 0 | SEC↗ |